Dina Wassaf Email

Director . Anokion

Current Roles

Employees:
39
Revenue:
$3M
About
Anokion, a spin-off from the Ecole Polytechnique Fédérale de Lausanne (EPFL), is focused on applying the company?s antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases. As a platform technology, Anokion?s approach to antigen-specific tolerance can be translated to virtually any protein in numerous clinical indications. www.anokion.com
Anokion Address
50 Hampshire Street
Cambridge, MA
United States
Anokion Email

Past Companies

AnokionDirector
AnokionAssociate Director
Kanyos BioSenior Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.